Smartleaf Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237 Sell
25
-70
-74% -$627 ﹤0.01% 3317
2025
Q4
$784 Hold
95
﹤0.01% 3202
2025
Q3
$1.31K Buy
95
+25
+36% +$330 ﹤0.01% 2698
2025
Q2
$895 Sell
70
-25
-26% -$344 ﹤0.01% 2494
2025
Q1
$1.43K Sell
95
-62
-39% -$1.06K ﹤0.01% 2545
2024
Q4
$2.83K Buy
157
+132
+528% +$1.78K ﹤0.01% 2432
2024
Q3
$329 Sell
25
-35
-58% -$516 ﹤0.01% 2834
2024
Q2
$816 Buy
+60
New +$950 ﹤0.01% 2453

Other funds holding CCRN

Smartleaf Asset Management's CCRN Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Cross Country Healthcare (CCRN) stake by 74% in Q1 2026, selling an estimated $627 and leaving 25 shares worth $237. The position accounts for ﹤0.01% of the portfolio, ranked #3317.

Smartleaf Asset Management first reported a position in CCRN in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.83K in Q4 2024. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Smartleaf Asset Management held 25 shares of Cross Country Healthcare worth $237 as of Q1 2026.
  • Smartleaf Asset Management sold 70 Cross Country Healthcare shares in Q1 2026, an estimated $627.
  • Cross Country Healthcare made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3317 holding.
  • Smartleaf Asset Management first reported a position in Cross Country Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Cross Country Healthcare position peaked at $2.83K in Q4 2024.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.